Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,903.50    -9.50 (-0.50%)
Bid:
1,904.00
Ask:
1,905.00
Spread: 1.00 (0.053%)
Market Cap: £76.34b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

LONDON BRIEFING: Stocks red, China exports surge before Trump tariffs
13 Jan 2025

LONDON BRIEFING: Stocks red, China exports surge before Trump tariffs

(Alliance News) - The FTSE 100 was called lower on Monday, after Friday's US jobs data strengthened Federal Reserve hawks' hand and made rate cuts les...

GSK to buy IDRx for up to $1.15bn
13 Jan 2025

GSK to buy IDRx for up to $1.15bn

(Sharecast News) - GSK on Monday said it was buying US-based biopharmaceutical company IDRx for up to $1.15bn.

GSK awaits FDA review of new shingles vaccine presentation
10 Jan 2025

GSK awaits FDA review of new shingles vaccine presentation

(Alliance News) - GSK PLC on Friday reported the US Food & Drug Administration has accepted its Shingrix vaccine syringe for review.

GSK application for new Shingrix formulation accepted by FDA
10 Jan 2025

GSK application for new Shingrix formulation accepted by FDA

(Sharecast News) - GSK announced on Friday that the US Food and Drug Administration (FDA) has accepted its regulatory application for a prefilled syri...

GSK hails FDA breakthrough therapy designation for bone cancer drug
7 Jan 2025

GSK hails FDA breakthrough therapy designation for bone cancer drug

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form...

LONDON BRIEFING: Next ups guidance after strong Christmas trade
7 Jan 2025

LONDON BRIEFING: Next ups guidance after strong Christmas trade

(Alliance News) - Stocks in London are set to open lower on Tuesday, with a eurozone inflation reading, and US data in focus.

GSK cancer drug candidate gets another breakthrough designation
7 Jan 2025

GSK cancer drug candidate gets another breakthrough designation

(Sharecast News) - GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy designation...

London close: Stocks finish first week of 2025 weaker
3 Jan 2025

London close: Stocks finish first week of 2025 weaker

(Sharecast News) - London stock markets closed in the red on Friday as sharp declines in airline, mining, and housebuilding stocks weighed on indices,...